Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,544 | -14,526 | -12,186 | -6,113 | -2,000 |
| Depreciation Amortization | 174 | 551 | 401 | 250 | 118 |
| Accounts receivable | -129 | -79 | -235 | -294 | -109 |
| Other Working Capital | -39 | -2,171 | -1,905 | -1,529 | -1,624 |
| Other Operating Activity | 3,022 | 5,802 | 6,379 | 2,652 | 452 |
| Operating Cash Flow | $-2,516 | $-10,423 | $-7,546 | $-5,034 | $-3,163 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -227 | 3,389 | 3,656 | 3,683 | -9 |
| Investing Cash Flow | $-227 | $3,389 | $3,656 | $3,683 | $-9 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -400 | -400 | N/A | -400 |
| Debt Repayment | N/A | N/A | N/A | -400 | N/A |
| Common Stock Issued | N/A | 36,052 | 36,052 | 20,641 | N/A |
| Financing Cash Flow | $N/A | $35,652 | $35,652 | $20,241 | $-400 |
| Beginning Cash Position | 40,138 | 11,520 | 11,520 | 11,520 | 11,520 |
| End Cash Position | 37,395 | 40,138 | 43,282 | 30,410 | 7,948 |
| Net Cash Flow | $-2,743 | $28,618 | $31,762 | $18,890 | $-3,572 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,516 | -10,423 | -7,546 | -5,034 | -3,163 |
| Capital Expenditure | -227 | -308 | -41 | -14 | -9 |
| Free Cash Flow | -2,743 | -10,731 | -7,587 | -5,048 | -3,172 |